Does chronic duodenal inflammation blunt CCK and secretin release and reduce pancreatic enzyme and bicarbonate secretion?

The regulation of pancreatic function is heavily dependent on the integrity of the duodenal mucosa. Cholecystokinin (CCK) and secretin are the primary hormonal mediators of the "gut-pancreas axis," and their synthesis and release are sensitive to local inflammatory environments.

Clinical and Physiological Evidence

The pancreatic phase of digestion is driven by the release of hormones from the duodenum in response to food intake.

• Hormonal Mediators: Secretin is released by S-cells in the duodenum primarily in response to acidic chyme, while CCK is released by I-cells in response to fats and proteins. These signals are critical for the postprandial release of digestive enzymes and bicarbonate.
• Secondary Pancreatic Insufficiency: Clinical data indicates that chronic duodenal inflammation, such as that seen in Celiac disease, Crohn's disease, or chronic duodenitis, often leads to functional exocrine pancreatic insufficiency (EPI). In Celiac disease, for example, approximately 28% of patients demonstrate low fecal elastase-1 levels (a marker of pancreatic output) despite having a structurally normal pancreas.
• Reversibility: Evidence suggests this reduction in output is often "enterogenous" and reversible. When the duodenal mucosa heals (e.g., following a gluten-free diet in Celiac patients), hormonal signaling is typically restored, leading to an improvement in pancreatic secretion.

Mechanistic Explanations

The reduction in pancreatic output during chronic inflammation is driven by the physical and functional disruption of the duodenal lining.

• Enteroendocrine Cell Dysfunction: Chronic inflammation can lead to villous atrophy and the loss or dysfunction of enteroendocrine cells (EECs). This depletion of I-cells and S-cells directly reduces the available pool of CCK and secretin.
• Signal Blunting: CCK acts via a vagal afferent pathway to stimulate enzyme-rich secretion from acinar cells, while secretin acts on ductal cells to initiate bicarbonate-rich fluid secretion through CFTR channels. Inflammation blunts the concentration of these hormones in the circulation, resulting in a weakened stimulus for the pancreatic secretory apparatus.
• Synergy Loss: Under healthy conditions, secretin and CCK work synergistically to maximize digestive efficiency. The blunting of either signal disrupts this synergy, significantly reducing the total volume and enzymatic concentration of the pancreatic juice entering the small intestine.

Bottom line

The claim is well-supported by physiological and clinical evidence. Chronic duodenal inflammation disrupts the enteroendocrine signaling (CCK and secretin) necessary for pancreatic stimulation, leading to secondary pancreatic insufficiency that is distinct from primary pancreatic disease.